Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Caribou Biosciences Inc.

    NASDAQ: CRBU · Real-Time Price · USD
    1.29
    -0.06 (-4.44%)
    At close: Jun 27, 2025, 3:59 PM
    1.26
    -2.33%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    Caribou Biosciences Statistics

    Share Statistics

    Caribou Biosciences has 93M shares outstanding. The number of shares has increased by 2.97% in one year.

    Shares Outstanding

    n/a
    		 93M

    Shares Change (YoY)

    n/a
    		 2.97%

    Shares Change (QoQ)

    n/a
    		 2.71%

    Owned by Institutions (%)

    n/a
    		 64.42%

    Shares Floating

    n/a
    		 80.97M

    Failed to Deliver (FTD) Shares

    n/a
    		 15,672

    FTD / Avg. Volume

    n/a
    		 1.39%

    Short Selling Information

    The latest short interest is 10.95M, so 11.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10.95M

    Short % of Shares Out

    n/a
    		 11.78%

    Short % of Float

    n/a
    		 12.34%

    Short Ratio (days to cover)

    n/a
    		 8.39

    Valuation Ratios

    The PE ratio is -0.96 and the forward PE ratio is -0.96. Caribou Biosciences's PEG ratio is -0.05.

    PE Ratio

    n/a
    		 -0.96

    Forward PE

    n/a
    		 -0.96

    PS Ratio

    n/a
    		 14.37

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.57

    P/FCF Ratio

    n/a
    		 -1

    PEG Ratio

    n/a
    		 -0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Caribou Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.16, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 7.16

    Quick Ratio

    n/a
    		 7.16

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.16

    Debt / FCF

    n/a
    		 -0.19

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $67,986.39

    Profits Per Employee

    n/a
    		 $-1,014,319.73

    Employee Count

    n/a
    		 147

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -9K

    Effective Tax Rate

    n/a
    		 0.01%

    Stock Price Statistics

    The stock price has increased by -21.34% in the last 52 weeks. The beta is 2.44, so Caribou Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.44

    52-Week Price Change

    n/a
    		 -21.34%

    50-Day Moving Average

    n/a
    		 1.01

    200-Day Moving Average

    n/a
    		 1.48

    Relative Strength Index (RSI)

    n/a
    		 55.28

    Average Volume (20 Days)

    n/a
    		 1,124,788

    Income Statement

    In the last 12 months, Caribou Biosciences had revenue of 9.99M and earned -149.1M in profits. Earnings per share was -1.65.

    Revenue

    n/a
    		 9.99M

    Gross Profit

    n/a
    		 6.07M

    Operating Income

    n/a
    		 -166.62M

    Net Income

    n/a
    		 -149.1M

    EBITDA

    n/a
    		 -166.62M

    EBIT

    n/a
    		 -166.62M

    Earnings Per Share (EPS)

    n/a
    		 -1.65
    Full Income Statement

    Balance Sheet

    The company has 16.29M in cash and 26.49M in debt, giving a net cash position of -10.19M.

    Cash & Cash Equivalents

    n/a
    		 16.29M

    Total Debt

    n/a
    		 26.49M

    Net Cash

    n/a
    		 -10.19M

    Retained Earnings

    n/a
    		 -448.39M

    Total Assets

    n/a
    		 273.66M

    Working Capital

    n/a
    		 188.83M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -138.2M and capital expenditures -4.88M, giving a free cash flow of -143.08M.

    Operating Cash Flow

    n/a
    		 -138.2M

    Capital Expenditures

    n/a
    		 -4.88M

    Free Cash Flow

    n/a
    		 -143.08M

    FCF Per Share

    n/a
    		 -1.58
    Full Cash Flow Statement

    Margins

    Gross margin is 60.71%, with operating and profit margins of -1667.16% and -1491.95%.

    Gross Margin

    n/a
    		 60.71%

    Operating Margin

    n/a
    		 -1667.16%

    Pretax Margin

    n/a
    		 -1492.04%

    Profit Margin

    n/a
    		 -1491.95%

    EBITDA Margin

    n/a
    		 -1667.16%

    EBIT Margin

    n/a
    		 -1667.16%

    FCF Margin

    n/a
    		 -1431.66%

    Dividends & Yields

    CRBU does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CRBU is $8.5, which is 558.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8.5

    Price Target Difference

    n/a
    		 558.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -2.51

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist